Deborah Watkins Bruner on Side Effects From Platinum-Based Drugs in Ovarian Cancer
Deborah Watkins Bruner, PhD, RN, FAAN, from the Nell Hodgson Woodruff School of Nursing at Emory University, discusses side effects associated with platinum-based drugs for the treatment of ovarian cancer.
Deborah Watkins Bruner Discusses Physician and Patient Reports of Toxicity
Deborah Watkins Bruner, PhD, RN, FAAN, professor, Nell Hodgson Woodruff School of Nursing, Emory University, discusses differences between physician and patient reports of toxicity.
Liso-Cel Elicits Rapid, Durable Responses in Relapsed/Refractory CLL/SLL
Adding Azoles May Not Impact Efficacy of Ruxolitinib in Acute GVHD Treatment
Ruxolitinib Plus Belumosudil Confers a 55% Response Rate in GVHD
Ruxolitinib Cream Improves Body Surface Area in Cutaneous GVHD
2 Commerce Drive Cranbury, NJ 08512